Skip to content

SPECTRALIS Software V7.4-US

by Heidelberg Engineering GmbH

SPECTRALIS Software V7.4-US is a Class II device made by Heidelberg Engineering GmbH, cleared under FDA 510(k) K253837 on 7 May 2026 and listed in FDA GUDID since 7 Jul 2026 (UDI-DI 04059237000976), active as of 12 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 12 Nov 2026

Documents

510(k) K253837

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 12 Nov 2026.

Regulatory status

as of registry sync 12 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number04059237000976 UDI-DI Date7 Jul 2026ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK253837 Date7 May 2026DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K253837 decided 7 May 2026 Active
  • FDA GUDID UDI-DI 04059237000976 listed 7 Jul 2026 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K253837
  2. Listed FDA GUDID 04059237000976

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Spectralis
Generic name
Scanning-laser retinal imaging system
Model / reference
Software V7.4-US
Primary DI / UDI-DI
04059237000976
510(k) Number
FDA product code
MYC, OBO
GMDN term
Scanning-laser retinal imaging system
Device class
Class II
Regulation number
886.1570
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code MYC (Ophthalmoscope, Laser, Scanning).

Other devices from Heidelberg Engineering GmbH

See all devices from Heidelberg Engineering GmbH →

Properties

  • Prescription use
  • Manufacturing date
Other properties (13, all answered No)